- CVS Caremark to stop selling tobacco in all store locations
- CVS Caremark showcases outreach program to help customers understand health insurance options
- Report: Specialty pharmacy to account for half of all prescription revenue by 2018
- CVS' Merlo: Health reform to benefit business in 2014
- MinuteClinic enters Northern California, Coastal Southeastern North Carolina
WOONSOCKET, R.I., and NEW YORK — Accordant Health Services, a CVS Caremark company, and the Michael J. Fox Foundation for Parkinson's Research on Wednesday announced a collaboration to provide to patients with Parkinson's disease who are enrolled in Accordant-sponsored care management programs information about resources available through the foundation.
Accordant provides care management services for people with rare, chronic conditions. As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today.
Through this collaboration, The Michael J. Fox Foundation's research experts will contribute content for Accordant patient newsletters and mailings about Parkinson's disease and available treatments, as well as the latest updates on research. The foundation also will share with Accordant patients information about the importance of participating in clinical research, and education on Fox Trial Finder, a new Web-based solution that is designed to make it easier for volunteers to find the specific Parkinson's clinical trials that need them.
"Accordant is excited to work with The Michael J. Fox Foundation. Both of our organizations share a commitment to supporting patients with Parkinson's disease as they proactively seek how to get the best out of their treatment," said Andrew Krueger, medical director for Accordant Health Services. "This partnership enables us to connect patients with Parkinson's disease with access to cutting edge information and updates on research, disease information to supplement the education and support we provide, and a resource to find current clinical trials and access to the support and resources the Foundation can offer to them and their families."
"Our foundation wants PD patients and their loved ones to know they can play a vital role in helping speed a cure," added Todd Sherer, CEO of The Michael J. Fox Foundation. "Our collaboration with Accordant will help us provide the Parkinson's community with information and tools that can help them get involved and make a difference for everyone living with the disease."